J Diéval

526 total citations
20 papers, 381 citations indexed

About

J Diéval is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, J Diéval has authored 20 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Surgery. Recurrent topics in J Diéval's work include Blood Coagulation and Thrombosis Mechanisms (6 papers), Hemophilia Treatment and Research (5 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (4 papers). J Diéval is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (6 papers), Hemophilia Treatment and Research (5 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (4 papers). J Diéval collaborates with scholars based in France, Switzerland and Canada. J Diéval's co-authors include J Delobel, Sylvie Gross, G. Nguyen, EK Kruithof, Sylvie Jorieux, Claudine Mazurier, M Goudemand, A. Fournier, P. Morinière and Jean‐Michel Achard and has published in prestigious journals such as Blood, British Journal of Haematology and Thrombosis and Haemostasis.

In The Last Decade

J Diéval

19 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Diéval France 7 298 83 59 54 51 20 381
Scott Cooper United States 10 187 0.6× 93 1.1× 63 1.1× 96 1.8× 103 2.0× 14 353
UM Marzec United States 7 393 1.3× 30 0.4× 74 1.3× 122 2.3× 74 1.5× 9 472
MJ Heeb United States 6 260 0.9× 31 0.4× 136 2.3× 20 0.4× 43 0.8× 8 347
Zhong-Fu Huang United States 7 274 0.9× 41 0.5× 104 1.8× 19 0.4× 19 0.4× 9 368
Vijoy Chowdhury United Kingdom 8 476 1.6× 69 0.8× 121 2.1× 16 0.3× 46 0.9× 9 543
Verónica Palma‐Barqueros Spain 10 212 0.7× 12 0.1× 53 0.9× 40 0.7× 19 0.4× 15 288
Inge Scharrer Germany 6 239 0.8× 12 0.1× 72 1.2× 63 1.2× 26 0.5× 8 344
Guy Cantin Canada 9 159 0.5× 11 0.1× 79 1.3× 24 0.4× 15 0.3× 23 276
E. Scelzi Italy 6 33 0.1× 44 0.5× 156 2.6× 75 1.4× 27 0.5× 11 311
Giovanna Scenna Italy 7 100 0.3× 7 0.1× 71 1.2× 14 0.3× 54 1.1× 8 297

Countries citing papers authored by J Diéval

Since Specialization
Citations

This map shows the geographic impact of J Diéval's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Diéval with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Diéval more than expected).

Fields of papers citing papers by J Diéval

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Diéval. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Diéval. The network helps show where J Diéval may publish in the future.

Co-authorship network of co-authors of J Diéval

This figure shows the co-authorship network connecting the top 25 collaborators of J Diéval. A scholar is included among the top collaborators of J Diéval based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Diéval. J Diéval is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Diéval, J, et al.. (2005). Le point sur les médicaments d'origine plasmatique dans le traitement des maladies hémorragiques et des maladies thrombotiques. Hématologie. 11(3). 189–200. 1 indexed citations
2.
Fressinaud, Édith, J Diéval, Valérie Gay, et al.. (2005). FranceCoag Network: A National Multicenter Prospective Cohort for Congenital Bleeding Disorders.. Blood. 106(11). 4094–4094. 2 indexed citations
3.
4.
Hottelart, C, et al.. (1998). Heparin‐Induced Hyperkalemia in Chronic Hemodialysis Patients: Comparison of Low Molecular Weight and Unfractionated Heparin. Artificial Organs. 22(7). 614–617. 30 indexed citations
5.
Diéval, J, et al.. (1996). Déficit en facteur XI, un nouveau moyen de substitution: les concentrés humains purifiés. Annales Françaises d Anesthésie et de Réanimation. 15(8). 1207–1210. 5 indexed citations
6.
Diéval, J, et al.. (1994). Characterization of von Willebrand factor gene defects in two unrelated patients with type IIC von Willebrand disease. Blood. 84(4). 1024–1030. 54 indexed citations
7.
Lormeau, B., Xavier Debussche, J Diéval, Bruno Tribout, & Jean‐Daniel Lalau. (1993). [Fibrinolysis and diabetes mellitus: a role in degenerative complications?].. PubMed. 144(2). 108–16. 1 indexed citations
8.
Gross, Sylvie, et al.. (1992). EFFICACY OF HIGH‐DOSE INTRAVENOUS GAMMAGLOBULIN IN THE MANAGEMENT OF ACQUIRED VON WILLEBRAND'S DISEASE DURING ORTHOPAEDIC SURGERY. British Journal of Haematology. 82(1). 170–171. 18 indexed citations
9.
Diéval, J, J Delobel, F Fernandez-Rachubinski, et al.. (1991). Antithrombin III‐Amiens: A new family with an Arg47 → cys inherited variant of antithrombin iii with impaired heparin cofactor activity. American Journal of Hematology. 36(1). 25–29. 6 indexed citations
10.
Diéval, J, G. Nguyen, Sylvie Gross, J Delobel, & EK Kruithof. (1991). A lifelong bleeding disorder associated with a deficiency of plasminogen activator inhibitor type 1. Blood. 77(3). 528–532. 115 indexed citations
11.
Diéval, J, G. Nguyen, Sylvie Gross, J Delobel, & EK Kruithof. (1991). A lifelong bleeding disorder associated with a deficiency of plasminogen activator inhibitor type 1. Blood. 77(3). 528–532. 3 indexed citations
12.
13.
14.
15.
Morinière, P., et al.. (1989). Low-Molecular-Weight Heparin Fraxiparin® in Chronic Hemodialysis. Blood Purification. 7(6). 301–308. 8 indexed citations
16.
Roussel, Bernard, et al.. (1988). [Effects of 2 doses of lysine acetylsalicylate on platelet aggregation, beta-thromboglobulin and platelet factor 4 in aged atherosclerotic patients].. PubMed. 43(4). 267–71. 1 indexed citations
17.
Diéval, J, et al.. (1987). [Anticoagulation in hemodialysis sessions with a low molecular weight heparin (CY 222, Choay). Dosage studies in chronic hemodialysis. Its use in patients at high risk of hemorrhage].. PubMed. 12 Suppl B. 114–8. 1 indexed citations
18.
Diéval, J, et al.. (1987). A NEW ASYMPTOMATIC TYPE III VARIANT OF ANTITHROMBIN III WITH DECREASE HEPARIN COFACTOR ACTIVITY : AT III AMIENS. Thrombosis and Haemostasis. 1 indexed citations
19.
Renaud, H, et al.. (1985). Low molecular weight heparin in haemodialysis and haemofiltration--comparison with unfractioned heparin.. PubMed. 21. 276–80. 1 indexed citations
20.
Delobel, J, et al.. (1981). Filterability in children. Scandinavian Journal of Clinical and Laboratory Investigation. 41(sup156). 49–51. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Scott Cooper Breakdown of academic impact, for papers by UM Marzec Breakdown of academic impact, for papers by MJ Heeb Breakdown of academic impact, for papers by Zhong-Fu Huang Breakdown of academic impact, for papers by Vijoy Chowdhury Breakdown of academic impact, for papers by Verónica Palma‐Barqueros Breakdown of academic impact, for papers by Inge Scharrer Breakdown of academic impact, for papers by Guy Cantin Breakdown of academic impact, for papers by E. Scelzi Breakdown of academic impact, for papers by Giovanna Scenna
Rankless by CCL
2026